For Research Use Only
PT-141 (Bremelanotide) 10mg
Melanocortin receptor agonist • Peptide for experimental receptor-pathway research • Not for human or veterinary use
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist peptide being investigated for its influence on
MC3R/MC4R pathways and associated neurobiological signaling. Research models explore PT-141 for its
role in neuromodulation, behavioral response pathways, and melanocortin system activity.
Current studies focus on its receptor-specific interactions and their downstream biochemical effects.
Key Research Points
- Investigated for its effect on melanocortin MC3R and MC4R receptor pathways
- Used in research exploring neuropeptide signaling and central nervous system modulation
- Evaluated for behavioral and neural response modeling in controlled studies
- Valuable for advanced neurobiological and receptor-specific peptide research
Form
Lyophilized Peptide Powder
Content
10mg per vial
Appearance
White lyophilized powder
Storage
Store dry at < 25°C. Refrigerate after reconstitution.
Disclaimer: For laboratory research use only. Not approved for human or veterinary use, ingestion,
or medical applications. Handle using sterile technique and appropriate laboratory PPE.
or medical applications. Handle using sterile technique and appropriate laboratory PPE.
